MULLEN JAMES C

EDIT

MULLEN JAMES C serves as CEO at Editas Medicine, Inc. (EDIT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.16M

Total Sells

2 trades

$1.02M

Net Position

Net Buyer

$139.8K

Companies Traded

EDIT

Active Period

Mar 2021 – Jan 2022

3 total trades

Most Recent

Sell EDIT

Jan 3, 2022 · $492.0K

MULLEN JAMES C's Insider Trading at Editas Medicine, Inc. (EDIT)

Buys

1 · $1.16M

Sells

2 · $1.02M

Total Shares Bought

25,000

Total Shares Sold

32,057

EDIT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 3, 2022↗	Sell	18,252	$26.95	$492.0K
Oct 18, 2021↗	Sell	13,805	$38.03	$525.0K
Mar 2, 2021↗	Buy	25,000	$46.27	$1.16M

Related Insiders

Linda Burkly

officer: EVP, CHIEF SCIENTIFIC OFFICER

EDITSell · Mar 3, 2026

Gilmore Neil O'Neill

director, officer: CEO

EDITSell · Mar 3, 2026

Amy Parison

officer: SVP, Chief Financial Officer

EDITSell · Mar 3, 2026

Linda Burkly

EVP, CHIEF SCIENTIFIC OFFICER

EDITSell · Dec 3, 2025

Gilmore Neil O'Neill

CEO

EDITSell · Dec 3, 2025

Amy Parison

SVP, Chief Financial Officer

EDITSell · Dec 3, 2025

Explore More Insider Trading Data

EDIT Insider Trading Activity

View all insider trades at Editas Medicine, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity